Core Viewpoint - The company, Global Medical (02666.HK), announced the issuance of domestic medium-term notes with a total principal amount of up to RMB 200 million [1] Group 1: Issuance Details - The first phase of the notes was completed on November 10, 2025, with an actual issuance amount of RMB 200 million [1] - The notes have a fixed interest rate of 2.08% and will mature in two years from November 11, 2025 [1] - The issuance price is set at RMB 100.0 per note, equivalent to 100% of the face value [1]

Core Viewpoint - The company plans to issue a total principal amount of up to RMB 200 million in domestic medium-term notes to institutional investors in China, with the proceeds aimed at repaying maturing debts [1] Group 1 - The issuance will be conducted by the company's wholly-owned subsidiary, Universal Global International Financing Leasing (Tianjin) Co., Ltd [1] - The first phase of the notes will have a duration of two years and will feature a fixed interest rate [1] - The final interest rate will be determined through a book-building process at the time of subscription application [1]

Core Viewpoint - The company, Universal Medical (02666), announced that its wholly-owned subsidiary, Universal Global International Financing Leasing (Tianjin) Co., Ltd., plans to issue a maximum principal amount of RMB 200 million in the first phase of domestic medium-term notes for 2025, with the proceeds intended for debt repayment [1]. Group 1 - The total principal amount of the medium-term notes to be issued is up to RMB 200 million [1]. - The first phase of the notes will have a duration of two years and will feature a fixed interest rate [1]. - The net proceeds from the issuance will be used by the issuer to repay maturing debts [1].